Anaxomics’ Methodologies. Understanding the Complexity of Biological Processes

Biological processes arise from nature’s inherent complexity, and they involve many components connected with positive and negative feedback, sometimes with redundant circuitry, sometimes with differential pathways in different individuals, sometimes with blurry, and conditional and variable connectivity patterns. In consequence, an intuitive understanding of their dynamics is hard to obtain. Anaxomics’ proprietary TPMS technology consists of a compendium of cutting-edge computational tools to mathematically model any biological process.

Spotlight

Medichem, S.A.

Meet an independently-owned developer and manufacturer of Finished Dosage Forms (FDF) , Active Pharmaceutical Ingredients (API) and HPAPI. From its headquarters in Barcelona, Spain, Medichem has grown into one of the largest worldwide manufacturers of Generics and Chlorhexidine in the pharmaceutical industry. Made up of a workforce of 450 talented individuals located in Spain (HQ), the USA, Malta and China, Medichem serves 60 countries worldwide.

OTHER WHITEPAPERS
news image

Biocontamination control in pharmaceutical production

whitePaper | November 11, 2022

Biocontamination refers to biological contamination of products by bacteria and/or fungi, as well as the toxic by-products of these microorganisms, such as endotoxin and mycotoxins from Gram-negative bacteria and fungi, respectively.

Read More
news image

Healthcare system readiness for the adoption of advanced therapies: learnings from the introduction of CAR T cell therapies in the UK

whitePaper | September 17, 2021

The adoption of CAR T therapies in the UK NHS is a success story, especially seen in relation to the experience in many other countries. The UK NHS showed itself to be agile, and responsive to addressing the unique challenges these therapies present, which facilitated access to patients earlier than in many other countries. (including delivery centre selection, development of service specifications, collaboration with manufacturers throughout the preparation phase for adoption, establishment of national multidisciplinary CAR T team to ensure equity of access and prioritization of resources (where needed)).

Read More
news image

Biotech Talent Management

whitePaper | February 2, 2022

While many sectors were dealt a severe blow by the COVID-19pandemic, biotech and medtech saw continued growth andare thus attracting top candidates even for non-scientific roles.

Read More
news image

Recruitment, Retention & Diversity: The Evolution of Patient Engagement in Clinical Trials

whitePaper | January 23, 2023

Recruitment, retention, and diversity are critical elements of clinical trials that, if insufficient, can jeopardize successful trial completion.

Read More
news image

Biosimilars in the United States 2023–2027

whitePaper | January 31, 2023

The first biosimilar approved under the abbreviated pathway established by the Biologics Price Competition and Innovation Act launched in the U.S. in 2015.

Read More
news image

Automated Extraction of High Molecular Weight DNA

whitePaper | November 14, 2019

SmartExtraction significantly simplifies the entire automated workflow of DNA extraction, setting new standards with regard to efficiency, yield and quality of the DNA.

Read More

Spotlight

Medichem, S.A.

Meet an independently-owned developer and manufacturer of Finished Dosage Forms (FDF) , Active Pharmaceutical Ingredients (API) and HPAPI. From its headquarters in Barcelona, Spain, Medichem has grown into one of the largest worldwide manufacturers of Generics and Chlorhexidine in the pharmaceutical industry. Made up of a workforce of 450 talented individuals located in Spain (HQ), the USA, Malta and China, Medichem serves 60 countries worldwide.

Events